GE HealthCareGEHCEarnings & Financial Report
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
GEHC Q1 FY2026 Key Financial Metrics
Revenue
$5.1B
Gross Profit
$2.0B
Operating Profit
$515.0M
Net Profit
$411.0M
Gross Margin
38.5%
Operating Margin
10.0%
Net Margin
8.0%
YoY Growth
7.4%
EPS
$0.85
GE HealthCare Q1 FY2026 Financial Summary
GE HealthCare reported revenue of $5.1B (up 7.4% YoY) for Q1 FY2026, with a net profit of $411.0M (down 31.0% YoY) (8.0% margin). Cost of goods sold was $3.2B, operating expenses totaled $1.5B.
Key Financial Metrics
| Total Revenue | $5.1B |
|---|---|
| Net Profit | $411.0M |
| Gross Margin | 38.5% |
| Operating Margin | 10.0% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
GE HealthCare Q1 FY2026 revenue of $5.1B breaks down across 5 segments, led by Imaging revenues at $2.3B (44.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Imaging revenues | $2.3B | 44.8% |
| AVS revenues | $1.3B | 26.1% |
| PDx revenues | $770.0M | 15.0% |
| PCS revenues | $704.0M | 13.7% |
| Other revenues | $18.0M | 0.4% |
GE HealthCare Annual Revenue by Year
GE HealthCare annual revenue history includes year-by-year totals (for example, 2025 revenue was $20.6B).
GE HealthCare Quarterly Revenue & Net Profit History
GE HealthCare results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $5.1B | +7.4% | $411.0M | 8.0% |
| Q4 FY2025 | $5.7B | +7.1% | $588.0M | 10.3% |
| Q3 FY2025 | $5.1B | +5.8% | $446.0M | 8.7% |
| Q2 FY2025 | $5.0B | +3.5% | $486.0M | 9.7% |
| Q1 FY2025 | $4.8B | +2.7% | $564.0M | 11.8% |
| Q4 FY2024 | $5.3B | +2.2% | $721.0M | 13.6% |
| Q3 FY2024 | $4.9B | +0.9% | $470.0M | 9.7% |
| Q2 FY2024 | $4.8B | +0.5% | $428.0M | 8.8% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.84B | $4.86B | $5.32B | $4.78B | $5.01B | $5.14B | $5.70B | $5.13B |
| YoY Growth | 0.5% | 0.9% | 2.2% | 2.7% | 3.5% | 5.8% | 7.1% | 7.4% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $31.85B | $33.85B | $33.09B | $33.59B | $35.50B | $36.13B | $36.91B | $37.13B |
| Liabilities | $23.86B | $25.34B | $24.44B | $24.17B | $25.55B | $25.91B | $26.31B | $26.23B |
| Equity | $7.80B | $8.32B | $8.45B | $9.19B | $9.71B | $9.99B | $10.38B | $10.68B |
Cash Flow
| Q2 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|
| Operating CF | $-119.0M | $250.0M | $94.0M |